Transabdominal ultrasound (TUS) is a fast, safe, and well-established screening modality for identifying pancreas, liver, and biliary tract pathology in the pediatric population. A subset of patients with findings that are incompletely characterized by ultrasound or who have no sonographic evidence of disease but persistent clinical suspicion may receive magnetic resonance cholangiopancreatography (MRCP). Pediatric inpatients who obtain an MRCP often experience longer inpatient stays, higher costs and delays in management. Relying on the sonographic findings or pursuing more advanced imaging as an outpatient may be a better option. To our knowledge, there have been no studies that have assessed whether inpatient MRCP performed following TUS in pediatric patients resulted in significant changes to additional inpatient treatment rendered. Our group ultimately looks to develop interdepartmental guidelines on when pursuit of an inpatient MRCP after TUS is indicated.
SPR 2018 Annual Meeting & Postgraduate Course